MoneyWorks4Me

Abbott India informs about board meeting

23 Jan 2019 Evaluate

In terms of Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that a meeting of the Board of Directors of the company is scheduled to be held on Friday, February 8, 2019, to consider and approve the text of Unaudited Financial Results of the company for the third quarter and nine months ended on December 31, 2018. Further, in terms of the company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window of the company shall remain closed from Friday, February 1, 2019 to Sunday, February 10, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..